Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/14/2006 | US20060204518 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
09/14/2006 | US20060204517 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
09/14/2006 | US20060204490 Hemostatic compositions containing sterile thrombin |
09/14/2006 | US20060204451 Chewing gum in the form of multi-layer tablets |
09/14/2006 | US20060204450 Pharmaceutical Compositions Based On Anticholinergics and PDE 5-Inhibitors |
09/14/2006 | US20060204449 Nasal pharmaceutical composition of piribedil |
09/14/2006 | US20060204448 Powdery preparation for nasal administration |
09/14/2006 | US20060204447 Delivering, via small particle aerosol, aqueous dispersions of anti-cancer drugs in liposomes or lipid complexes to respiratory tract of an individual in need of such treatment |
09/14/2006 | US20060204446 Topical immunotherapy and compositions for use therein |
09/14/2006 | US20060204442 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
09/14/2006 | US20060204440 Radio-opaque polymeric biomaterials |
09/14/2006 | US20060201886 Method for determining the binding behavior of ligands which specifically bind to target molecules |
09/14/2006 | DE102005011786A1 Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen A process for the production of ultrafine submicron suspensions |
09/14/2006 | DE102005011367A1 Verfahren zur Herstellung von Cellulosesulfat mit verbesserten Eigenschaften A process for the production of cellulose sulfate with improved characteristics |
09/14/2006 | DE102005011029A1 Zusammensetzung für die perorale Applikation mit gesteuerter Freisetzung von Wirkstoffen A composition for oral administration with controlled release of active ingredients |
09/14/2006 | DE102005010419A1 Active agent application device, useful as wound cover, comprises edition part for edition on skin and/or tissue from liquid storing and delivering material, covering layer, feeding equipment that has tube section and connecting substance |
09/14/2006 | DE102005005173A1 Wirkstoffhaltige Selbstklebemassen und deren Herstellung Active ingredient-containing self-adhesive compositions and their preparation |
09/14/2006 | CA2745782A1 Pharmaceutical compositions and uses for peptide treatment |
09/14/2006 | CA2623112A1 Method for producing ultrafine submicronic suspensions |
09/14/2006 | CA2602007A1 Particle and preparation containing the particle |
09/14/2006 | CA2601114A1 Pharmacological, chemical, and topical agent enhancement apparatus and method for using same |
09/14/2006 | CA2601011A1 Sugar-coated pill |
09/14/2006 | CA2600969A1 Soft gelatin capsules containing cyclodextrin in the capusle shell |
09/14/2006 | CA2600638A1 Composition comprising emodepside and praziquantel or epsiprantel |
09/14/2006 | CA2600370A1 Bioactive fus1 peptides and nanoparticle-polypeptide complexes |
09/14/2006 | CA2600178A1 Novel method for obtaining a fast-dissolving imidapril powder |
09/14/2006 | CA2600085A1 Microparticle and pharmaceutical preparation |
09/14/2006 | CA2599968A1 Topical gels compositions |
09/14/2006 | CA2599758A1 Pharmaceutical compositions comprising sirolimus and/or an analogue thereof |
09/14/2006 | CA2599733A1 Methods and compositons for modified release of nutritional supplements |
09/14/2006 | CA2599699A1 Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
09/14/2006 | CA2599697A1 Chemically defined stabiliser composition |
09/14/2006 | CA2599290A1 Ketoprofen sis adhesive for skin adhesive plaster |
09/14/2006 | CA2599251A1 Microemulsions of cannabinoid receptor binding compounds |
09/14/2006 | CA2598503A1 New ophthalmologic compositions and their method of use |
09/14/2006 | CA2598353A1 Non-fibrous transdermal therapeutic system and method for its production |
09/14/2006 | CA2598288A1 Nanoparticulate compositions of heterocyclic amide derivatives |
09/14/2006 | CA2596031A1 Injectable preparations of diclofenic and its pharmaceutically acceptable salts |
09/14/2006 | CA2595033A1 Gastroresistant pharmaceutical formulations containing rifaximin |
09/13/2006 | EP1700616A1 Compounds for the treatment of ocular dryness caused by photorefractive surgery |
09/13/2006 | EP1700615A1 Device for intradermal medicament delivery |
09/13/2006 | EP1700605A2 Lyophilized methionine-containing protein preparations stabilized over long time |
09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
09/13/2006 | EP1700602A1 Pharmaceutical composition for use in hormone replacement therapy |
09/13/2006 | EP1700597A1 Pharmaceutical composition containing in association ubidecarenone, dexpanthenol and chlorhexidine or a pharmaceutically acceptable salt thereof for cutaneous application |
09/13/2006 | EP1700595A1 Tablets having an emulsified polymer matrix for the controlled emission of gas, and production process |
09/13/2006 | EP1700593A1 Water-in-Oil dispersion comprising dextran fatty acid ester |
09/13/2006 | EP1700591A1 Method for treatment of solid pharmaceutical preparation prior to printing and solid pharmaceutical preparation subjected to treatment prior to printing |
09/13/2006 | EP1699847A1 Medicinal compositions and method for the preparation thereof |
09/13/2006 | EP1699837A1 Stereocomplex hydrogels with tunable degradation times |
09/13/2006 | EP1699549A2 Systems for preparing fine particles and other substances |
09/13/2006 | EP1699529A1 Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent |
09/13/2006 | EP1699500A1 Crosslinked hyaluronic acid compositions for tissue augmentation |
09/13/2006 | EP1699474A2 Probiotic tablet formulations |
09/13/2006 | EP1699465A1 Treatment |
09/13/2006 | EP1699458A1 Pharmaceutical composition |
09/13/2006 | EP1699446A1 Compositions and methods for treating hepatitis c virus (hcv) infection |
09/13/2006 | EP1699445A1 Collagen and polysaccharide-based coating composition |
09/13/2006 | EP1699443A2 Pharmaceutical formulations of bisphosphonates |
09/13/2006 | EP1699442A2 Enteric coated aliphatic amine polymer bile acid sequestrants |
09/13/2006 | EP1699441A2 Fast-disintegrating tablets |
09/13/2006 | EP1699440A1 Method for the production of an administration form which is secured against misuse |
09/13/2006 | EP1699439A2 Controlled-release pharmaceutical formulation |
09/13/2006 | EP1699438A2 Pharmaceutical preparation containing gabapentin |
09/13/2006 | EP1699437A2 Method for preparing solid dosage form of desmopressin |
09/13/2006 | EP1699436A2 Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure |
09/13/2006 | EP1699435A1 Particles |
09/13/2006 | EP1699434A1 Process for preparing a medicament |
09/13/2006 | EP1699433A2 Oleaginous pharmaceutical and cosmetic foam |
09/13/2006 | EP1699432A2 Injectable phosphatidylcholine preparations |
09/13/2006 | EP1699431A2 Compositions for treatment of ear disorders and methods of use thereof |
09/13/2006 | EP1699430A1 Patch |
09/13/2006 | EP1699393A2 Drug delivery device with mechanical locking mechanism |
09/13/2006 | EP1699309A1 Inhaler for basic pharmaceutical agents and method for production thereof |
09/13/2006 | EP1628642B1 Controlled drug release composition resistant to in vivo mechanic stress |
09/13/2006 | EP1578325A4 Stable topical drug delivery compositions |
09/13/2006 | EP1485067B1 Materials containing multiple layers of vesicles |
09/13/2006 | EP1395252B1 Medicaments for treating colics |
09/13/2006 | EP1385452B1 Ophthalmic drug delivery device |
09/13/2006 | EP1360958B1 Liposomic formulation of clobetasol propionate |
09/13/2006 | EP1331948B1 Pharmaceutical composition containing honey for the treatment of wounds |
09/13/2006 | EP1296645B1 Methods for treating inflammation-mediated conditions of the eye |
09/13/2006 | EP1274406B1 Pharmaceutical formulations for dry powder inhalers in the form of hard-pellets |
09/13/2006 | EP1267843B1 System for transporting active substances in a biological system |
09/13/2006 | EP1246617B1 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of ovarian cancer |
09/13/2006 | EP1227801B1 Multi-layer preparation in film form, consisting of hydrophilic polymers, for the rapid release of active ingredients |
09/13/2006 | EP1200067B1 Method for the preparation of microparticles comprising biological material |
09/13/2006 | EP1196431B1 A substantially crystalline form of melagatran |
09/13/2006 | EP1196146B1 Powder particles with smooth surface for use in inhalation therapy |
09/13/2006 | EP1179344B1 Release-regulating preparations |
09/13/2006 | EP1165126B1 Process for preparing a human papillomavirus vaccine with disassembled and reassembled virus-like particles |
09/13/2006 | EP1079807B1 Use of preparations for the application of antiseptic agents and/or agents promoting the healing of wounds to the lower respiratory tract |
09/13/2006 | EP1071402B1 Process for the manufacture of (sub)micron sized particles by dissolving in compressed gas and surfactants |
09/13/2006 | EP0965340B1 Dermatologic preparation |
09/13/2006 | EP0957817B1 Locking couplings for osmotic delivery devices |
09/13/2006 | EP0939608B1 Device and gel for acidic buffering |
09/13/2006 | EP0921774B1 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
09/13/2006 | EP0813399B1 Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof |
09/13/2006 | CN2815405Y Medicine plaster for gynecology department |
09/13/2006 | CN2815404Y Perfume health-care chain essential oil bag |